The combination of GIP plus xenin-25 indirectly increases pancreatic polypeptide release in humans with and without type 2 diabetes mellitus

Regulatory Peptides

Volumn 187, Issue , 2013, Pages 42-50

  Chowdhury, Sara ^a   Wang, Songyan ^a   Patterson, Bruce W ^a   Reeds, Dominic N ^a   Wice, Burton M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cholinergic; GIP; Neuronal relay; Neurotensin receptor; Pancreatic polypeptide; Xenin

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; INSULIN; MUSCARINIC RECEPTOR; NEUROTENSIN; NEUROTENSIN RECEPTOR; PANCREAS POLYPEPTIDE; UNCLASSIFIED DRUG; XENIN 25;

ARTICLE; BLOOD VESSEL; CENTRAL NERVOUS SYSTEM; CHOLINERGIC SYSTEM; ENDOCRINE CELL; ENDOTHELIUM CELL; EPITHELIUM CELL; GLUCOSE INFUSION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; NERVE FIBER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SYMPATHETIC NERVE CELL;

MUS;

ALB; ALBUMIN ALONE; CHOLINERGIC; G+X; GIP; GIP PLUS XEN; GLP-1; GLUCAGON-LIKE PEPTIDE-1; GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE; IGT; IMPAIRED GLUCOSE TOLERANCE; INSULIN SECRETION RATE; INTRAVENOUS GRADED GLUCOSE INFUSIONS; ISR; IVGGIS; NEURONAL RELAY; NEUROTENSIN RECEPTOR; NEUROTENSIN RECEPTOR-1; NGT; NORMAL GLUCOSE TOLERANCE; NTSR1; PANCREATIC POLYPEPTIDE; PANCREATIC POLYPEPTIDE RESPONSE; PP; PPR; T2DM; TYPE 2 DIABETES MELLITUS; XEN; XENIN; XENIN-25;

ADULT; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHOLINERGIC NEURONS; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRIC INHIBITORY POLYPEPTIDE; HUMANS; MALE; MIDDLE AGED; NEUROTENSIN; PANCREAS; PANCREATIC POLYPEPTIDE; PANCREATIC POLYPEPTIDE-SECRETING CELLS; RECEPTORS, NEUROTENSIN;

EID: 84888131978     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2013.10.003     Document Type: Article

References (53)

1. Brand S.J., Schmidt W.E. Gastrointestinal hormones. Textbook of gastroenterology 1995, 25-71. JB Lippincott Company, Philadelphia. 2nd ed. T. Yamada (Ed.).
2. Walsh J.H. Gastrointestinal hormones. Physiology of the gastrointestinal tract 1994, 1-128. Raven Press, New York. 3rd ed. L.R. Johnson (Ed.).
3. Fehmann H., Goke R., Goke B. Cell and molecular biology of the incretin hormones glucagon-like peptide-1 and glucose-dependent insulin releasing polypeptide. Endocr Rev 1995, 16:390-410.
4. Baggio L.L., Drucker D.J. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007, 132:2131-2157.
5. Ahren B. Neuropeptides and insulin secretion. International textbook of diabetes mellitus 2004, 153-163. John Wiley & Sons, Ltd, Hoboken, New Jersey. 3rd ed. R.A. DeFronzo, E. Ferrannini, H. Keen, P. Zimmet (Eds.).
6. Nauck M., Stockmann F., Ebert R., Creutzfeldt W. Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia 1986, 29:46-52.
7. Meier J.J., Nauck M.A. Is the diminished incretin effect in type 2 diabetes just an epi-phenomenon of impaired beta-cell function?. Diabetes 2010, 59:1117-1125.
8. Nauck M.A. Incretin-based therapies for type 2 diabetes mellitus: properties, functions, and clinical implications. Am J Med 2011, 124:S3-S18.
9. Lovshin J.A., Drucker D.J. Incretin-based therapies for type 2 diabetes mellitus. Nat Rev Endocrinol 2009, 5:262-269.
10. Deacon C.F., Nauck M.A., Meier J., Hucking K., Holst J.J. Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide. J Clin Endocrinol Metab 2000, 85:3575-3581.
11. Elahi D., McAloon-Dyke M., Fukagawa N.K., Meneilly G.S., Sclater A.L., Minaker K.L., Habener J.F., Andersen D.K. The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects. Regul Pept 1994, 51:63-74.
12. Vilsboll T., Krarup T., Madsbad S., Holst J.J. Defective amplification of the late phase insulin response to glucose by GIP in obese type II diabetic patients. Diabetologia 2002, 45:1111-1119.
13. Wice B.M., Reeds D.R., Tran H., Crimmins D.L., Patterson B.W., Dunai J., Wallendorf M.J., Ladenson J.H., Villareal D.T., Polonsky K.S. Xenin-25 amplifies GIP-mediated insulin secretion in humans with normal and impaired glucose tolerance, but not type 2 diabetes. Diabetes 2012, 61:1793-1800.
14. Anlauf M., Weihe E., Hartschuh W., Hamscher G., Feurle G.E. Localization of xenin-immunoreactive cells in the duodenal mucosa of humans and various mammals. J Histochem Cytochem 2000, 48:1617-1626.
15. Zhang S., Hyrc K., Wang S., Wice B.M. Xenin-25 increases cytosolic free calcium levels and acetylcholine release from a subset of myenteric neurons. Am J Physiol Gastrointest Liver Physiol 2012, 303:G1347-G1355.
16. Kitabgi P., Kwan C.Y., Fox J.E., Vincent J.P. Characterization of neurotensin binding to rat gastric smooth muscle receptor sites. Peptides 1984, 5:917-923.
17. Wice B.M., Wang S., Crimmins D.L., Diggs-Andrews K.A., Althage M.C., Ford E.L., Tran H., Ohlendorf M., Griest T.A., Wang Q., Fisher S.J., Ladenson J.H., Polonsky K.S. Xenin-25 potentiates glucose-dependent insulinotropic polypeptide action via a novel cholinergic relay mechanism. J Biol Chem 2010, 285:19842-19853.
18. Kirchgessner A.L., Gershon M.D. Innervation of the pancreas by neurons in the gut. J Neurosci 1990, 10:1626-1642.
19. Kirchgessner A.L., Adlersberg M.A., Gershon M.D. Colonization of the developing pancreas by neural precursors from the bowel. Dev Dyn 1992, 194:142-154.
20. Amenta F., Cavallotti C., de Rossi M., Tonelli F., Vatrella F. The cholinergic innervation of human pancreatic islets. Acta Histochem 1983, 73:273-278.
21. Shimosegawa T., Asakura T., Kashimura J., Yoshida K., Meguro T., Koizumi M., Mochizuki T., Yanaihara N., Toyota T. Neurons containing gastrin releasing peptide-like immunoreactivity in the human pancreas. Pancreas 1993, 8:403-412.
22. Bishop A.E., Polak J.M., Green I.C., Bryant M.G., Bloom S.R. The location of VIP in the pancreas of man and rat. Diabetologia 1980, 18:73-78.
23. Rodriguez-Diaz R., Dando R., Jacques-Silva M.C., Fachado A., Molina J., Abdulreda M.H., Ricordi C., Roper S.D., Berggren P.O., Caicedo A. Alpha cells secrete acetylcholine as a non-neuronal paracrine signal priming beta cell function in humans. Nat Med 2011, 17:888-892.
24. Rodriguez-Diaz R., Abdulreda M.H., Formoso A.L., Gans I., Ricordi C., Berggren P.O., Caicedo A. Innervation patterns of autonomic axons in the human endocrine pancreas. Cell Metab 2011, 14:45-54.
25. Adrian T.E., Besterman H.S., Cooke T.J., Bloom S.R., Barnes A.J., Russell R.C. Mechanism of pancreatic polypeptide release in man. Lancet 1977, 1:161-163.
26. Adrian T.E. Pancreatic polypeptide. J Clin Pathol Suppl (Assoc Clin Pathol) 1978, 8:43-50.
27. Lonovics J., Devitt P., Watson L.C., Rayford P.L., Thompson J.C. Pancreatic polypeptide. A review. Arch Surg 1981, 116:1256-1264.
28. Fletcher D.R., Shulkes A., Bladin P.H., Hardy K.J. The effect of atropine on bombesin and gastrin releasing peptide stimulated gastrin, pancreatic polypeptide and neurotensin release in man. Regul Pept 1983, 7:31-40.
29. Kim E.R., Mizuno T.M. Role of neurotensin receptor 1 in the regulation of food intake by neuromedins and neuromedin-related peptides. Neurosci Lett 2010, 468:64-67.
30. Feurle G.E., Metzger J.W., Grudinki A., Hamscher G. Interaction of xenin with the neurotensin receptor of guinea pig enteral smooth muscles. Peptides 2002, 23:1519-1525.
31. Pettibone D.J., Hess J.F., Hey P.J., Jacobson M.A., Leviten M., Lis E.V., Mallorga P.J., Pascarella D.M., Snyder M.A., Williams J.B., Zeng Z. The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin. J Pharmacol Exp Ther 2002, 300:305-313.
32. Nustede R., Schmidt W.E., Horstmann O., Sikovec N., Schemminger R., Becker H. On the effect of xenin and xenin fragments on exocrine pancreas secretion in vivo. Regul Pept 1999, 81:61-66.
33. Clemens A., Katsoulis S., Nustede R., Seebeck J., Seyfarth K., Morys-Wortmann C., Feurle G.E., Folsch U.R., Schmidt W.E. Relaxant effect of xenin on rat ileum is mediated by apamin-sensitive neurotensin-type receptors. Am J Physiol 1997, 272:G190-G196.
34. Feurle G.E., Pfeiffer A., Schmidt T., Dominguez-Munoz E., Malfertheiner P., Hamscher G. Phase III of the migrating motor complex: associated with endogenous xenin plasma peaks and induced by exogenous xenin. Neurogastroenterol Motil 2001, 13:237-246.
35. Nauck M.A., Heimesaat M.M., Orskov C., Holst J.J., Ebert R., Creutzfeldt W. Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest 1993, 91:301-307.
36. Wang S.Y., Liu J., Li L., Wice B.M. Individual sub-types of enteroendocrine cells in the mouse small intestine exhibit unique patterns of inositol 1,4,5-trisphosphate receptor expression. Journal of Histochemistry and Cytochemistry 2004, 52:53-63.
37. Amland P.F., Jorde R., Aanderud S., Burhol P.G., Giercksky K.E. Effects of intravenously infused porcine GIP on serum insulin, plasma C-peptide, and pancreatic polypeptide in non-insulin-dependent diabetes in the fasting state. Scand J Gastroenterol 1985, 20:315-320.
38. Ardeleanu C., Arsene D., Hinescu M., Andrei F., Gutu D., Luca L., Popescu L.M. Pancreatic expression of DOG1: a novel gastrointestinal stromal tumor (GIST) biomarker. Appl Immunohistochem Mol Morphol 2009, 17:413-418.
39. Dodge R., Loomans C., Sharma A., Bonner-Weir S. Developmental pathways during in vitro progression of human islet neogenesis. Differentiation 2009, 77:135-147.
40. Brimnes D.M., Rasmussen B.K., Hilsted L., Jensen R., Hilsted J. Basal serum pancreatic polypeptide is dependent on age and gender in an adult population. Scand J Clin Lab Invest 1997, 57:695-702.
41. Amland P.F., Jorde R., Burhol P.G., Giercksky K.E. Effects of atropine on GIP-induced insulin and pancreatic polypeptide release in man. Scand J Gastroenterol 1985, 20:321-324.
42. Dixon A.F., le Roux C.W., Ghatei M.A., Bloom S.R., McGee T.L., Dixon J.B. Pancreatic polypeptide meal response may predict gastric band-induced weight loss. Obes Surg 2011, 21:1906-1913.
43. Schmidt P.T., Naslund E., Gryback P., Jacobsson H., Holst J.J., Hilsted L., Hellstrom P.M. A role for pancreatic polypeptide in the regulation of gastric emptying and short-term metabolic control. J Clin Endocrinol Metab 2005, 90:5241-5246.
44. Elek J., Pinzon W., Park K.H., Narayanan R. Relevant genomics of neurotensin receptor in cancer. Anticancer Res 2000, 20:53-58.
45. Wang L., Friess H., Zhu Z., Graber H., Zimmermann A., Korc M., Reubi J.C., Buchler M.W. Neurotensin receptor-1 mRNA analysis in normal pancreas and pancreatic disease. Clin Cancer Res 2000, 6:566-571.
46. Reubi J.C., Waser B., Friess H., Buchler M., Laissue J. Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma. Gut 1998, 42:546-550.
47. Kirchgessner A.L., Gershon M.D. Innervation and regulation of the pancreas by neurons in the gut. Z Gastroenterol Verh 1991, 26:230-233.
48. Teff K.L., Townsend R.R. Prolonged mild hyperglycemia induces vagally mediated compensatory increase in C-Peptide secretion in humans. J Clin Endocrinol Metab 2004, 89:5606-5613.
49. Silvestre J.S., Prous J. Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes. Methods Find Exp Clin Pharmacol 2005, 27:289-304.
50. Duttaroy A., Zimliki C.L., Gautam D., Cui Y., Mears D., Wess J. Muscarinic stimulation of pancreatic insulin and glucagon release is abolished in m3 muscarinic acetylcholine receptor-deficient mice. Diabetes 2004, 53:1714-1720.
51. Unger R.H., Cherrington A.D. Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover. J Clin Invest 2012, 122:4-12.
52. Meier J.J., Gallwitz B., Siepmann N., Holst J.J., Deacon C.F., Schmidt W.E., Nauck M.A. Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia. Diabetologia 2003, 46:798-801.
53. Elahi D., Andersen D.K., Brown J.C., Debas H.T., Hershcopf R.J., Raizes G.S., Tobin J.D., Andres R. Pancreatic alpha- and beta-cell responses to GIP infusion in normal man. Am J Physiol 1979, 237:E185-E191.